Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes.
. .
Related Articles:
- Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
- Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction
- Indications for Renal Arteriography at the Time of Coronary Arteriography: A Science Advisory From the American Heart Association Committte on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease.